In vitro screening of antifungal compounds able to counteract biofilm development

Marion Girardot1, Christine Imbert

  • 1Laboratory of ecology and biology of the interactions, Faculty of Medicine Pharmacy, University of Poitiers, UMR CNRS 7267, 6, rue de la Miletrie - BP 199, 86034, Poitiers, France.

Insights

Researchers developed rapid screening methods to find new anti-fungal biofilm compounds. These techniques assess both preventative and curative effects against Candida yeast biofilms on various surfaces.

Area of Science:

  • Mycology
  • Microbiology
  • Drug Discovery

Background:

  • Fungal biofilms on inert surfaces and host tissues pose a significant risk for human infections.
  • Current therapeutic options against fungal biofilms are limited, necessitating the discovery of new anti-biofilm agents.

Purpose of the Study:

  • To describe rapid, 96-well microtiter plate-based methods for screening anti-biofilm compounds.
  • To evaluate compounds for their efficacy against Candida spp. biofilms using both prophylactic and curative approaches.

Main Methods:

  • Utilized 96-well microtiter plates for high-throughput screening of anti-biofilm compounds.
  • Assessed compound activity against Candida biofilms formed on polystyrene surfaces and catheter sections.
  • Employed both prophylactic (preventative) and curative treatment strategies.

Main Results:

  • Detailed methods for rapid screening of anti-fungal biofilm activity are presented.
  • The described methods allow for the evaluation of compounds against Candida biofilms.
  • Both prophylactic and curative effects can be assessed on different surfaces.

Conclusions:

  • Established robust screening methods for identifying novel anti-biofilm molecules against Candida yeasts.
  • The described assays provide a foundation for discovering new therapeutic strategies against fungal biofilm infections.
  • These methods facilitate the search for effective agents to combat challenging fungal biofilms.